On May 18, 2021, National Resilience announced that the Government of Canada will invest CAD 199.2 million ($163.8 million), through the Strategic Innovation Fund, in the companyﾒs Ontario-based subsidiary Resilience Biotechnologies Inc. (RBI) to modernize and expand production capacity.